Benjamin Walbaum, Medical Oncologist at Pontifical Catholic University of Chile, shared a post on LinkedIn:
“SABCS 2025 – Key Takeaways for the LATAM Oncology Community
The San Antonio Breast Cancer Symposium (SABCS) 2025 once again highlighted how rapidly the breast cancer treatment landscape is evolving, from endocrine strategies to biomarker-driven decision-making.
With Dr Alexandra Garcilazo from the Instituto Nacional de Cancerología – México, we discuss clinically relevant insights discussed at SABCS, with clear implications for daily practice and research priorities—particularly important for oncology teams across Latin America, where access to diagnostics and novel therapies remains heterogeneous.
Why this matters
Emerging data may redefine adjuvant and post-neoadjuvant strategies in hormone receptor–positive disease.
Increasing emphasis on biomarkers to better identify patients who truly benefit from treatment escalation.
Growing gap between scientific innovation and real-world access, underscoring the need for context-adapted implementation in LMIC settings.
LATAM perspective
Translating global trial results into regional practice requires critical appraisal, local data generation, and collaborative efforts to ensure eqity in breast cancer care.
Watch the full video here.”
More posts featuring Benjamin Walbaum on OncoDaily.